Open-Labelled, Multicenter Phase II Study of Rituximab in Patients With Steroid-Refractory Chronic Graft-Versus-Host Disease.
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 05 Mar 2009
At a glance
- Drugs Rituximab (Primary)
- Indications Graft-versus-host disease
- Focus Therapeutic Use
- 05 Mar 2009 Planned end date changed from 1 May 2008 to 1 May 2009.
- 20 Feb 2009 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 22 Aug 2007 Status changed from initiated to recruiting.